IntrepiCyte is focused on licensing its unique, noninvasive, proprietary intranasal therapeutic cell delivery technology which targets stem cells, immune cells, genetically engineered cells, and other therapeutic cells to damaged or diseased areas of the central nervous system in order to treat a variety of neurological, psychiatric, and behavioral disorders.
| Website | https://www.intrepicyte.com/ |
| Employees | 1 (1 on RocketReach) |
| Founded | 2023 |
| Industry | Biotechnology Research |
| Keywords | Stem Cell Therapy, Regenerative Medicine, Immune Cell Therapy, Targeted Drug Delivery, Biological Therapeutics, Cellular Therapeutics, Drug Delivery Systems, Regenerative Medicine Technology, Advanced Drug Delivery, Stem Cell Treatment, Cell Based Therapies, Nasal Drug Delivery |
Looking for a particular IntrepiCyte employee's phone or email?
IntrepiCyte Questions
William Frey is the CEO of IntrepiCyte.
1 people are employed at IntrepiCyte.
Top IntrepiCyte Employees
-
William Frey
Chief Executive Officer at IntrepiCyte
Saint Paul, MN, US35+
G2Crowd Trusted
300K+
Plugin Users
